(Q38733009)

5 September 2017

1 reference

title

Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes (English)

1 reference

5 September 2017

E Frigas

1

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

5 September 2017

1 reference

5 September 2017

volume

64

1 reference

5 September 2017

issue

10

1 reference

5 September 2017

page(s)

1269-1275

1 reference

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

An IgG autoantibody which inactivates C1-inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Autoantibody-mediated acquired deficiency of C1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlation with clinical and serological abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Angioedema induced by a peptide derived from complement component C2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Kinin formation: mechanisms and role in inflammatory disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Development of an immunochemical test to assess C1 inactivator function in human serum and its use for the diagnosis of hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Immunocytochemical Techniques for Identifying Leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Use of azide and hydrogen peroxide as an inhibitor for endogenous peroxidase in the immunoperoxidase method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Hereditary angioedema: a decade of management with stanozolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

HEREDITARY ANGIO-NEUROTIC ŒDEMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Hereditary angioneurotic edema of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Recurrent angioedema: familial and oestrogen-induced

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Peripheral T-cell lymphoma presenting with angioedema and diffuse pulmonary infiltrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Hereditary angioedema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

Acquired C1 Esterase Inhibitor Deficiency and Angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961290-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)61290-7

1 reference

5 September 2017

1 reference